Connecting oncology professionals with relevant clinical trials

Selected clinical trial

FUTURE: Phase II prospective non-randomized diagnostic study of FAPI PET imaging and liquid biopsy in bladder cancer

Sponsor: Universita' Vita-salute S. Raffaele

Phase: 2

Disease: Urothelial carcinoma of the bladder, High-grade non-muscle-invasive bladder cancer, Muscle-invasive bladder cancer

EU trial number: 2026-526990-40-00

Population: Adults aged ≥18 years with high-grade non-muscle-invasive or muscle-invasive urothelial bladder cancer, ECOG 0–1, eligible for imaging, blood and urine collection, and possible surgery/systemic therapy.

Register Investigator Interest

Interested in offering this trial to suitable patients?